BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit

NCT02190500 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1038

Last updated 2023-03-17

No results posted yet for this study

Summary

The primary goal of this project is to carry out a trial comparing pre-hospital diagnosis and treatment of patients with stroke symptoms using a Mobile Stroke Unit (MSU) with subsequent transfer to a Comprehensive Stroke Center (CSC) Emergency Department (ED) for further management, to standard pre-hospital triage and transport by Emergency Medical Services (EMS) to a CSC ED for evaluation and treatment (Standard Management-SM).

Conditions

  • Acute Ischemic Stroke

Interventions

OTHER

Mobile Stroke Unit Management

Mobile Stroke Unit is a standard 12' Houston Fire Department ambulance equipped with point of care lab, CT scanner and staffed by a Vascular Neurologist, Registered Nurse with acute stroke and research experience, CT Technician and a Registered EMT-P. The MSU is dispatched in coordination with Houston, Bellaire and West University fire department/emergency medical services.

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • CHI St. Luke's Health, Texas

    collaborator OTHER
  • City of Houston Fire Department

    collaborator UNKNOWN
  • The Methodist Hospital Research Institute

    collaborator OTHER
  • West University Fire Department

    collaborator UNKNOWN
  • City of Bellaire Fire Department

    collaborator UNKNOWN
  • Ben Taub Hospital

    collaborator OTHER
  • Harris Health

    collaborator UNKNOWN
  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • Memorial Hermann Health System

    lead OTHER

Principal Investigators

  • James C Grotta, MD · Memorial Hermann

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2021-12-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02190500 on ClinicalTrials.gov